|
Real-time Estimate
Cboe Europe
11:30:36 02/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 130.61 CHF | -0.27% |
|
+2.88% | +19.38% |
| 11:21am | Alteogen Signs KRW4.4 Trillion Option, Licensing Deal with Novartis for Subcutaneous Injections | MT |
| 09-01 | Health Care Up on Defensive Bias - Health Care Roundup | DJ |
| Market Cap | 307B 265B 249B 227B 426B 29,115B 429B 2,943B 1,145B 14,810B 1,152B 1,127B 49,107B | P/E 2026 * |
22.9x | P/E 2027 * | 19.5x |
|---|---|---|---|---|---|
| Enterprise Value | 339B 293B 275B 251B 472B 32,216B 474B 3,256B 1,267B 16,388B 1,274B 1,247B 54,339B | EV / Sales 2026 * |
5.89x | EV / Sales 2027 * | 5.46x |
| Free-Float |
91.66% | Yield 2026 * |
2.71% | Yield 2027 * | 2.82% |
Last Transcript : Novartis AG
| 1 day | -0.28% | ||
| 1 week | +2.88% | ||
| Current month | +6.15% | ||
| 1 month | +5.09% | ||
| 3 months | +15.79% | ||
| 6 months | +0.68% | ||
| Current year | +19.38% |
| 1 week | 122.64 |  | 132.48 |
| 1 month | 121.02 | | 132.48 |
| Current year | 107.68 | | 132.48 |
| 1 year | 96.03 | | 132.48 |
| 3 years | 81.1 | | 132.48 |
| 5 years | 72.84 | | 132.48 |
| 10 years | 65.09 | | 132.48 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 50 | 31/01/2018 | |
Mukul Mehta
DFI | Director of Finance/CFO | - | 15/03/2026 |
Karen Hale
CMP | Compliance Officer | 58 | 13/04/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Nancy Andrews
BRD | Director/Board Member | 67 | 31/12/2014 |
| Director/Board Member | 69 | 31/12/2015 | |
Ton Büchner
BRD | Director/Board Member | 61 | 31/12/2015 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 18/05/26 | Sell | -5,200 | 0.0003% | |||
| 04/05/26 | Sell | 6,800 | 0.0003% | |||
| 17/02/26 | Sell | 30,743 | 0.0015% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.27% | +2.88% | +29.29% | +46.96% | 307B | |
| +0.28% | -5.97% | +58.34% | +108.22% | 1,034B | |
| +2.01% | -0.71% | +53.07% | +68.99% | 654B | |
| +1.39% | -2.18% | +23.57% | +75.43% | 459B | |
| +1.02% | -4.72% | +33.93% | +36.19% | 343B | |
| -0.04% | -2.13% | +0.59% | +12.01% | 251B | |
| +1.92% | -0.93% | +52.28% | +70.67% | 237B | |
| +0.59% | -3.05% | -17.52% | -54.89% | 202B | |
| +2.45% | +0.77% | +32.71% | +95.59% | 186B | |
| +0.32% | -0.07% | +15.31% | -20.21% | 163B | |
| Average | +1.12% | -2.60% | +28.16% | +43.90% | 383.43B | |
| Weighted average by Cap. | +1.39% | -3.18% | +37.56% | +63.01% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 57.65B 49.73B 46.78B 42.61B 80.14B 5,471B 80.57B 553B 215B 2,783B 216B 212B 9,228B | 61.31B 52.88B 49.75B 45.32B 85.22B 5,819B 85.68B 588B 229B 2,960B 230B 225B 9,814B |
| Net income | 13.95B 12.03B 11.32B 10.31B 19.39B 1,324B 19.5B 134B 52.09B 674B 52.38B 51.24B 2,233B | 15.5B 13.37B 12.58B 11.46B 21.55B 1,471B 21.67B 149B 57.88B 748B 58.2B 56.94B 2,482B |
| Net Debt | 32.68B 28.19B 26.52B 24.16B 45.43B 3,102B 45.67B 313B 122B 1,578B 123B 120B 5,231B | 27.82B 24B 22.57B 20.56B 38.67B 2,640B 38.88B 267B 104B 1,343B 104B 102B 4,453B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 02/09/26 | CHF 130.80 | -0.12% | 658,868 |
| 01/09/26 | CHF 130.96 | +6.25% | 4,912,644 |
| 31/08/26 | CHF 123.26 | -0.39% | 2,544,960 |
| 28/08/26 | CHF 123.74 | -0.72% | 1,961,272 |
| 27/08/26 | CHF 124.64 | -2.00% | 1,891,362 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- NOVN Stock
Select your edition
All financial news and data tailored to specific country editions
